What is the appropriate work‑up for asthma with a high eosinophil count?

Work-Up for Asthma with High Eosinophil Count

For asthma patients with elevated eosinophil counts, measure fractional exhaled nitric oxide (FeNO) to confirm eosinophilic airway inflammation and predict corticosteroid responsiveness, then determine the absolute eosinophil count to guide further evaluation and treatment decisions.

Initial Assessment: Quantify the Eosinophilia

The first critical step is calculating the absolute eosinophil count (AEC) from the complete blood count 1:

• Mild eosinophilia: 500-1,500 cells/μL
• Hypereosinophilia: ≥1,500 cells/μL

This distinction matters because hypereosinophilia is rarely explained by allergy alone and mandates a more extensive work-up 1.

Core Diagnostic Testing

FeNO Measurement (Priority Test)

FeNO is strongly recommended to identify eosinophilic airway inflammation and predict steroid responsiveness 2. The ATS guidelines provide specific interpretation thresholds:

• FeNO >47 ppb: Highly predictive of steroid responsiveness (89% negative predictive value) and indicates likely loss of control if steroids are withdrawn 2
• FeNO 25-47 ppb: Moderate elevation supporting eosinophilic inflammation
• FeNO <22 ppb: Predicts successful steroid reduction (92% positive predictive value) 2

Key clinical utility: FeNO correlates with sputum eosinophils (r=0.59) and identifies steroid-responsive inflammation even when sputum eosinophils are absent 2. A FeNO <26 ppb has 85% negative predictive value for sputum eosinophils <3% 2.

Blood Eosinophil Thresholds for Treatment Decisions

Blood eosinophil counts serve as practical surrogates for airway eosinophilia 3:

• ≥2.7% or ≥260 cells/μL: Accurately predicts sputum eosinophilic asthma (92% sensitivity, 76% specificity) 3
• ≥150 cells/μL: Recommended threshold to guide anti-IL-5 therapy initiation 4
• ≥260 cells/μL with FeNO ≥19.5 ppb: Identifies greatest likelihood of anti-IgE response 4

Phenotype-Specific Considerations

Distinguishing Early-Onset vs. Adult-Onset Disease

The pathogenic role of eosinophils differs fundamentally by phenotype 5:

• Early-onset allergic asthma: Eosinophil counts are variable and allergen-dependent; eosinophils play a minor "sidekick" role
• Adult-onset intrinsic asthma: Persistently elevated eosinophils are primary disease drivers 5

This distinction has major implications for biologic selection and treatment strategy.

Historical Red Flags Requiring Extended Work-Up

When AEC ≥1,500 cells/μL (hypereosinophilia), investigate systematically 1:

Critical History Elements:

• Timing: Onset of eosinophilia and coincident events
• Travel history: Parasitic infections (most common infectious cause)
• Medication review: Drug-induced eosinophilia
• End-organ symptoms:
  • Cardiac (myocarditis, endomyocardial fibrosis)
  • Neurologic (peripheral neuropathy, CNS involvement)
  • Dermatologic (rashes, angioedema)
  • Gastrointestinal (eosinophilic GI disorders)

Additional Testing for Hypereosinophilia:

• Stool examination for ova and parasites (×3)
• Serum IgE levels
• Tryptase (mast cell disorders)
• Vitamin B12 (markedly elevated in myeloproliferative disorders)
• Cardiac evaluation if symptomatic
• Consider tissue biopsy of affected organs

Monitoring and Treatment Implications

For Eosinophilic Asthma (Confirmed by FeNO and Blood Eosinophils):

Baseline blood eosinophil count and maximum eosinophil levels predict treatment outcomes 6. Patients with higher maximum eosinophil counts (>660 cells/μL) and more frequent exacerbations (≥3/year) are significantly more likely to require multiple biologic switches 6.

Induced Sputum (When Available):

While induced sputum remains the gold standard for phenotyping 7, 8, it's not routinely necessary when blood eosinophils and FeNO are concordant. Reserve for:

• Discordant blood and FeNO results
• Suspected neutrophilic asthma
• Research or specialized centers

Sputum eosinophils ≥3% correlate with treatment response and show strong negative correlation with FEV1% predicted (r=-0.92) 8.

Common Pitfalls to Avoid

1. Don't assume all eosinophilia is asthma-related: Hypereosinophilia demands exclusion of parasites, drugs, and systemic disorders 1

2. Don't rely on FeNO alone for diagnosis: FeNO identifies eosinophilic inflammation and steroid responsiveness, not asthma per se. Non-eosinophilic asthma phenotypes exist with normal FeNO 2

3. Don't interpret FeNO in patients already on inhaled corticosteroids: Treatment suppresses FeNO, causing false negatives 2

4. Don't ignore maximum eosinophil counts: Peak values (not just baseline) predict biologic treatment requirements 6

5. Blood neutrophil counts poorly predict neutrophilic asthma: Unlike eosinophils, blood neutrophils are weak surrogates for airway neutrophilia 3